A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China

NCT04825873 · clinicaltrials.gov ↗

COMPLETED

Status

3102

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Sponsor

Bristol-Myers Squibb